Prerna Mewawalla, Myeloma and Transplant Physician, Director of Stem Cell Transplant and Cellular Therapy, Medical Director of Apheresis at Allegheny Health Network, shared on LinkedIn:
“Honored to be presenting at the 2026 Best of ASCO Conference.
I’ll be discussing key advances in multiple myeloma on Saturday, August 1 at 1:50 PM, including data from MajesTEC-9, CARES, SUCCESSOR-2 and other important studies shaping the evolving treatment landscape.
I look forward to exploring how these findings can be translated into practical treatment decisions and improved care for our patients.
I hope to see many colleagues there!”
Other articles about ASCO on OncoDaily.